What is Arcutis Biotherapeutics, Inc. Common Stock's Market Cap?

Arcutis Biotherapeutics, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Enterprise Value?

Arcutis Biotherapeutics, Inc. Common Stock's Enterprise Value is $3.1B, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Trailing P/E?

Arcutis Biotherapeutics, Inc. Common Stock's Trailing P/E is 105.1×, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Price / Sales?

Arcutis Biotherapeutics, Inc. Common Stock's Price / Sales is 6.5×, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's EV / Revenue?

Arcutis Biotherapeutics, Inc. Common Stock's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's EV / EBITDA?

Arcutis Biotherapeutics, Inc. Common Stock's EV / EBITDA is 84.4×, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

Arcutis Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $464.0M, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

Arcutis Biotherapeutics, Inc. Common Stock's Net Income (TTM) is $28.5M, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's EBITDA?

Arcutis Biotherapeutics, Inc. Common Stock's EBITDA is $37.2M, based on as-reported figures from SEC (XBRL) filings.

What is Arcutis Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Arcutis Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.23, based on as-reported figures from SEC (XBRL) filings.

Arcutis Biotherapeutics, Inc. Common Stock (ARQT) Financial Statements

Arcutis Biotherapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00QN8K4P1

XNAS · usd

23.84▼ 0.55 (-2.26%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close24.39

Day's Range23.74 – 24.46

52-Week Range16.57 – 31.77

Volume2.3M

Avg Volume1.8M

Share Statistics

Shares Outstanding

Employees354

ExchangeXNAS

Listed2020-01-31

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Arcutis Biotherapeutics, Inc. Common Stock (ARQT)

What is Arcutis Biotherapeutics, Inc. Common Stock's Market Cap?: Arcutis Biotherapeutics, Inc. Common Stock's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Enterprise Value?: Arcutis Biotherapeutics, Inc. Common Stock's Enterprise Value is $3.1B, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Trailing P/E?: Arcutis Biotherapeutics, Inc. Common Stock's Trailing P/E is 105.1×, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Price / Sales?: Arcutis Biotherapeutics, Inc. Common Stock's Price / Sales is 6.5×, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's EV / Revenue?: Arcutis Biotherapeutics, Inc. Common Stock's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's EV / EBITDA?: Arcutis Biotherapeutics, Inc. Common Stock's EV / EBITDA is 84.4×, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: Arcutis Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $464.0M, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: Arcutis Biotherapeutics, Inc. Common Stock's Net Income (TTM) is $28.5M, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's EBITDA?: Arcutis Biotherapeutics, Inc. Common Stock's EBITDA is $37.2M, based on as-reported figures from SEC (XBRL) filings.
What is Arcutis Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Arcutis Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.23, based on as-reported figures from SEC (XBRL) filings.